Avidity Biosciences Inc
Change company Symbol lookup
Select an option...
RNA Avidity Biosciences Inc
BAC Bank of America Corp
SDA SunCar Technology Group Inc
RAIN Rain Oncology Inc
EOI Eaton Vance Enhanced Equity Income Fund
OLNCF Omni Lite Industries Canada Inc
RGNX Regenxbio Inc
OGSYS Otis Gallery LLC
RDN Radian Group Inc
SLNO Soleno Therapeutics Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Avidity Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in delivering a new class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates (AOCs.). The Company's AOC platform is designed to combine the specificity of monoclonal antibodies (mAbs), with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with RNA therapeutics. The AOC platform also has the option to deploy various types of oligonucleotides, including small interfering RNA (siRNAs) and patient measure of safety (PMOs), whose specific mechanisms of action modify RNA function in different ways. The Company's pipeline includes AOC 1001, and AOC 1020. AOC 1001 is designed to treat people with myotonic dystrophy type 1 (DM1). AOC 1020 is designed to treat people living with facioscapulohumeral.

Price
Delayed
$10.92
Day's Change
0.045 (0.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.13
Day's Low
10.77
Volume
(Light)

Today's volume of 74,211 shares is on pace to be much lighter than RNA's 10-day average volume of 867,461 shares.

74,211
  • Prev Close
    10.87
  • Today's Open
    11.06
  • Day's Range
    10.77-11.13
  • Avg Vol (10-day)
    867.5K
  • Last (time)
    10:21a ET 06/02/23
  • Last (size)
    1
  • 52-Wk Range
    9.83 - 25.74
    LowHigh
  • (12/07/22 - 02/17/23)
    11.04%
  • 88.7%
  • Market Cap
    772.3M
  • Shares Outstanding
    70.8M
  • -3.36
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 98.43
  • (% of float 05/15/23)
    18.99

Latest News

May 22, 2023
4:05 pm ET
PR Newswire
7:03 am ET
MarketWatch
May 17, 2023
7:00 am ET
PR Newswire
May 09, 2023
4:05 pm ET
PR Newswire
April 27, 2023
3:40 pm ET
PR Newswire
April 24, 2023
2:02 pm ET
Globe Newswire
9:00 am ET
PR Newswire
April 21, 2023
4:05 pm ET
PR Newswire
April 20, 2023
1:49 pm ET
Globe Newswire
April 19, 2023
6:11 am ET
PR Newswire
April 17, 2023
9:00 am ET
PR Newswire
April 16, 2023
3:16 pm ET
Globe Newswire
April 14, 2023
11:47 am ET
Newsfile
April 13, 2023
9:00 am ET
PR Newswire
April 12, 2023
10:00 pm ET
Accesswire
April 09, 2023
1:37 am ET
Globe Newswire
April 04, 2023
8:05 pm ET
Accesswire
March 31, 2023
6:33 am ET
MarketWatch
March 30, 2023
5:12 pm ET
Globe Newswire
8:05 am ET
MarketWatch
7:07 am ET
PR Newswire
March 21, 2023
4:05 pm ET
PR Newswire
March 13, 2023
9:00 am ET
PR Newswire
December 14, 2022
8:09 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.